ARTICLE | Company News
Deltagen to acquire Arcaris
July 26, 2001 7:00 AM UTC
Genomics company DGEN will acquire functional proteomics play Arcaris (Salt Lake City, Utah) for 765,000 DGEN shares, valued at $6.8 million based on DGEN's Wednesday close at $8.84, plus $450,000 in ...